Reduction of Werner Syndrome Protein Enhances G:C → A:T Transition by O6-Methylguanine in Human Cells

Chem Res Toxicol. 2018 May 21;31(5):319-324. doi: 10.1021/acs.chemrestox.8b00009. Epub 2018 Apr 12.

Abstract

O6-Methylguanine ( O6-MeG) is a damaged base produced by methylating reagents. The Werner syndrome protein (WRN) is a cancer-related human DNA helicase. The effects of WRN reduction on O6-MeG-caused mutagenesis were assessed by an siRNA-mediated knockdown in human U2OS cells, using a shuttle plasmid with a single O6-MeG base in the supF gene. The plasmid DNA was replicated in the cells, isolated, and electroporated into an Escherichia coli indicator strain. The lowered amount of WRN increased the frequency of mutations induced by O6-MeG, mainly G:C → A:T substitution. The increased mutation rate suggested that the cancer-related WRN suppresses the G:C → A:T substitution by O6-MeG in human cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Guanine / analogs & derivatives*
  • Guanine / chemistry
  • Guanine / metabolism
  • Guanine / pharmacology
  • Humans
  • Mutation
  • Transcription, Genetic / drug effects*
  • Transcription, Genetic / genetics
  • Werner Syndrome Helicase / metabolism*

Substances

  • Guanine
  • O-(6)-methylguanine
  • WRN protein, human
  • Werner Syndrome Helicase